Pathological Complete Response to Pembrolizumab plus Axitinib Combination following Serious Immune-Related Adverse Events in an Advanced Renal Cell Carcinoma Patient with a History of Rheumatoid Arthritis
暂无分享,去创建一个
F. Valcamonico | T. Zanotelli | I. Caramella | Martina Buffoni | N. R. Suardi | A. Berruti | Marco Bergamini | A. Dalla Volta | Enrico Munari | Simona Fisogni